Chronic Illness as the Epicenter of Pharmaceutical Innovation: From Symptom Management to System Recalibration
Introduction For much of the 20th century, the pharmaceutical industry’s most significant innovations targeted acute problems such as infections or pain. Today, the center of gravity has shifted. The bulk of research and development pipelines, clinical trial portfolios, and healthcare expenditures are now focused on complex chronic illnesses. This transformation is driven by demographics (aging […]
